The stock of Balchem Corporation (NASDAQ:BCPC) reached all time high today, Oct, 5 and still has $109.18 target or 39.00% above today’s $78.55 share price. This indicates more upside for the $2.48B company. This technical setup was reported by Barchart.com. If the $109.18 PT is reached, the company will be worth $967.20M more.
Trading stocks at an all time highs is usually a winning strategy. An all time high points to a stock which has the most positive fundamentals ever. Even thought the pullback rate is high, if correct risk management is utilized, investors can trade very well such events. About 85,491 shares traded hands. Balchem Corporation (NASDAQ:BCPC) has risen 23.15% since March 2, 2016 and is uptrending. It has outperformed by 14.89% the S&P500.
Analysts await Balchem Corporation (NASDAQ:BCPC) to report earnings on November, 1.
According to Zacks Investment Research, “Balchem Corporation is engaged in the development, manufacture and marketing of specialty performance ingredients for the food, feed and medical sterilization industries. They operate in two business segments, the micro-encapsulation of performance ingredients and the repackaging and marketing of high quality specialty gases. They sell their products through their own sales force, independent distributors and sales agents.”
Insitutional Activity: The institutional sentiment increased to 1.22 in 2016 Q2. Its up 0.08, from 1.14 in 2016Q1. The ratio improved, as 11 funds sold all Balchem Corporation shares owned while 54 reduced positions. 14 funds bought stakes while 65 increased positions. They now own 24.68 million shares or 4.84% less from 25.93 million shares in 2016Q1.
Huntington Natl Bank reported 1,490 shares or 0% of all its holdings. Keybank Association Oh holds 0% or 6,163 shares in its portfolio. Moreover, Deutsche National Bank & Trust Ag has 0% invested in Balchem Corporation (NASDAQ:BCPC) for 39,115 shares. Blackrock has invested 0% of its portfolio in Balchem Corporation (NASDAQ:BCPC). Schroder Invest Mngmt Gp has 254,100 shares for 0.03% of their US portfolio. Great West Life Assurance Can holds 0% of its portfolio in Balchem Corporation (NASDAQ:BCPC) for 3,141 shares. Stifel Fincl Corporation holds 0.01% or 53,970 shares in its portfolio. Tci Wealth Incorporated, a Arizona-based fund reported 8 shares. Tower Research Limited Liability Company (Trc) accumulated 0.01% or 2,577 shares. Rocky Mountain Advisers Ltd Liability Com owns 20 shares or 0.01% of their US portfolio. Gsa Prns Llp reported 6,400 shares or 0.02% of all its holdings. Moreover, New York State Teachers Retirement System has 0.01% invested in Balchem Corporation (NASDAQ:BCPC) for 66,678 shares. Commonwealth Equity Svcs last reported 0% of its portfolio in the stock. Clearbridge Ltd Liability Corp last reported 197,380 shares in the company. Blackrock Fund, a California-based fund reported 1.99M shares.
Insider Transactions: Since May 19, 2016, the stock had 0 buys, and 7 sales for $4.44 million net activity. Shares for $1.07 million were sold by ROSSI DINO A. 12,000 shares were sold by Backus William A., worth $823,680 on Friday, August 26. 4,000 shares were sold by Houston Matthew David, worth $271,320 on Tuesday, September 20. The insider MCMILLAN EDWARD sold 1,500 shares worth $104,619.
More important recent Balchem Corporation (NASDAQ:BCPC) news were published by: Fool.com which released: “Balchem Corporation Revenue Drops on Weak Energy Demand” on February 29, 2016, also Marketwatch.com published article titled: “Balchem Corp. NASDAQ: BCPC”, Quotes.Wsj.com published: “News Balchem Corp.BCPC” on February 12, 2011. More interesting news about Balchem Corporation (NASDAQ:BCPC) was released by: Fool.com and their article: “Why Balchem Corporation’s Shares Popped 14% Today” with publication date: February 02, 2016.
BCPC Company Profile
Balchem Corporation (Balchem), incorporated on January 30, 1967, is engaged in the development, manufacture, distribution and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical and medical sterilization industries. The Firm operates in four divisions: SensoryEffects, Animal Nutrition & Health (ANH), Specialty Products and Industrial Products. The Firm sells its products through its own sales force, independent distributors and sales agents. The Company’s SensoryEffects segment provides creamer systems, dairy replacers, powdered fats, nutritional beverage bases, beverages, juice and dairy bases, chocolate systems, ice cream bases and variegates, ready-to-eat cereals, grain snacks and cereal ingredients. ANH segment provides basic choline chloride, and microencapsulation and chelation technologies nutritional products. Specialty Products segment provides ethylene oxide and propylene oxide products. The Company’s Industrial Products segment provides Choline Chloride and methylamines. The Company’s subsidiaries include SensoryEffects, Inc. (SE), SensoryEffects Cereal Systems, Inc. (SECS), BCP Ingredients, Inc. (BCP) and Aberco, Inc. (Aberco).
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.